United States Avian Influenza Vaccines Market Report & Forecast 2021-2027

Publisher Name :
Date: 08-Sep-2021
No. of pages: 110
Inquire Before Buying

United States Avian Influenza Vaccines Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (M Doses)

United States Avian Influenza Vaccines Market Segment Percentages, By Type, 2020 (%)

- H5+H7 Avian Influenza Vaccines

- H9 Avian Influenza Vaccines

United States Avian Influenza Vaccines Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (M Doses)

United States Avian Influenza Vaccines Market Segment Percentages, By Application, 2020 (%)

- Chicken Avian Influenza Vaccines

- Duck & Goose Avian Influenza Vaccines

- Other

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Avian Influenza Vaccines revenues in United States market, 2016-2021 (Estimated), ($ millions)

Key companies Avian Influenza Vaccines revenues share in United States market, 2020 (%)

Key companies Avian Influenza Vaccines sales in United States market, 2016-2021 (Estimated), (M Doses)

Key companies Avian Influenza Vaccines sales share in United States market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

- Merial

- QYH Biotech

- DHN

- HVRI

- CEVA

- Elanco (Lohmann )

- Yebio

- Zoetis

- FATRO

- Kyoto Biken

- CAVAC

- Ringpu Biology

- Vaksindo

- ChengDu Tecbond

- Sindh Poultry Vaccine Centre

- Merck Animal Health

- Medion

- Avimex Animal Health

- JOVAC

- Bio-Labs

United States Avian Influenza Vaccines Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Avian Influenza Vaccines Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Avian Influenza Vaccines Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Avian Influenza Vaccines Overall Market Size
2.1 United States Avian Influenza Vaccines Market Size: 2021 VS 2027
2.2 United States Avian Influenza Vaccines Revenue, Prospects & Forecasts: 2016-2027
2.3 United States Avian Influenza Vaccines Sales: 2016-2027
3 Company Landscape
3.1 Top Avian Influenza Vaccines Players in United States Market
3.2 Top United States Avian Influenza Vaccines Companies Ranked by Revenue
3.3 United States Avian Influenza Vaccines Revenue by Companies
3.4 United States Avian Influenza Vaccines Sales by Companies
3.5 United States Avian Influenza Vaccines Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Avian Influenza Vaccines Companies in United States Market, by Revenue in 2020
3.7 Manufacturers Avian Influenza Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Avian Influenza Vaccines Players in United States Market
3.8.1 List of Tier 1 Avian Influenza Vaccines Companies in United States
3.8.2 List of Tier 2 and Tier 3 Avian Influenza Vaccines Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Avian Influenza Vaccines Market Size Markets, 2021 & 2027
4.1.2 H5+H7 Avian Influenza Vaccines
4.1.3 H9 Avian Influenza Vaccines
4.2 By Type - United States Avian Influenza Vaccines Revenue & Forecasts
4.2.1 By Type - United States Avian Influenza Vaccines Revenue, 2016-2021
4.2.2 By Type - United States Avian Influenza Vaccines Revenue, 2022-2027
4.2.3 By Type - United States Avian Influenza Vaccines Revenue Market Share, 2016-2027
4.3 By Type - United States Avian Influenza Vaccines Sales & Forecasts
4.3.1 By Type - United States Avian Influenza Vaccines Sales, 2016-2021
4.3.2 By Type - United States Avian Influenza Vaccines Sales, 2022-2027
4.3.3 By Type - United States Avian Influenza Vaccines Sales Market Share, 2016-2027
4.4 By Type - United States Avian Influenza Vaccines Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Avian Influenza Vaccines Market Size, 2021 & 2027
5.1.2 Chicken Avian Influenza Vaccines
5.1.3 Duck & Goose Avian Influenza Vaccines
5.1.4 Other
5.2 By Application - United States Avian Influenza Vaccines Revenue & Forecasts
5.2.1 By Application - United States Avian Influenza Vaccines Revenue, 2016-2021
5.2.2 By Application - United States Avian Influenza Vaccines Revenue, 2022-2027
5.2.3 By Application - United States Avian Influenza Vaccines Revenue Market Share, 2016-2027
5.3 By Application - United States Avian Influenza Vaccines Sales & Forecasts
5.3.1 By Application - United States Avian Influenza Vaccines Sales, 2016-2021
5.3.2 By Application - United States Avian Influenza Vaccines Sales, 2022-2027
5.3.3 By Application - United States Avian Influenza Vaccines Sales Market Share, 2016-2027
5.4 By Application - United States Avian Influenza Vaccines Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Merial
6.1.1 Merial Corporation Information
6.1.2 Merial Overview
6.1.3 Merial Avian Influenza Vaccines Sales and Revenue in United States Market (2016-2021)
6.1.4 Merial Avian Influenza Vaccines Product Description
6.1.5 Merial Recent Developments
6.2 QYH Biotech
6.2.1 QYH Biotech Corporation Information
6.2.2 QYH Biotech Overview
6.2.3 QYH Biotech Avian Influenza Vaccines Sales and Revenue in United States Market (2016-2021)
6.2.4 QYH Biotech Avian Influenza Vaccines Product Description
6.2.5 QYH Biotech Recent Developments
6.3 DHN
6.3.1 DHN Corporation Information
6.3.2 DHN Overview
6.3.3 DHN Avian Influenza Vaccines Sales and Revenue in United States Market (2016-2021)
6.3.4 DHN Avian Influenza Vaccines Product Description
6.3.5 DHN Recent Developments
6.4 HVRI
6.4.1 HVRI Corporation Information
6.4.2 HVRI Overview
6.4.3 HVRI Avian Influenza Vaccines Sales and Revenue in United States Market (2016-2021)
6.4.4 HVRI Avian Influenza Vaccines Product Description
6.4.5 HVRI Recent Developments
6.5 CEVA
6.5.1 CEVA Corporation Information
6.5.2 CEVA Overview
6.5.3 CEVA Avian Influenza Vaccines Sales and Revenue in United States Market (2016-2021)
6.5.4 CEVA Avian Influenza Vaccines Product Description
6.5.5 CEVA Recent Developments
6.6 Elanco (Lohmann )
6.6.1 Elanco (Lohmann ) Corporation Information
6.6.2 Elanco (Lohmann ) Overview
6.6.3 Elanco (Lohmann ) Avian Influenza Vaccines Sales and Revenue in United States Market (2016-2021)
6.6.4 Elanco (Lohmann ) Avian Influenza Vaccines Product Description
6.6.5 Elanco (Lohmann ) Recent Developments
6.7 Yebio
6.7.1 Yebio Corporation Information
6.7.2 Yebio Overview
6.7.3 Yebio Avian Influenza Vaccines Sales and Revenue in United States Market (2016-2021)
6.7.4 Yebio Avian Influenza Vaccines Product Description
6.7.5 Yebio Recent Developments
6.8 Zoetis
6.8.1 Zoetis Corporation Information
6.8.2 Zoetis Overview
6.8.3 Zoetis Avian Influenza Vaccines Sales and Revenue in United States Market (2016-2021)
6.8.4 Zoetis Avian Influenza Vaccines Product Description
6.8.5 Zoetis Recent Developments
6.9 FATRO
6.9.1 FATRO Corporation Information
6.9.2 FATRO Overview
6.9.3 FATRO Avian Influenza Vaccines Sales and Revenue in United States Market (2016-2021)
6.9.4 FATRO Avian Influenza Vaccines Product Description
6.9.5 FATRO Recent Developments
6.10 Kyoto Biken
6.10.1 Kyoto Biken Corporation Information
6.10.2 Kyoto Biken Overview
6.10.3 Kyoto Biken Avian Influenza Vaccines Sales and Revenue in United States Market (2016-2021)
6.10.4 Kyoto Biken Avian Influenza Vaccines Product Description
6.10.5 Kyoto Biken Recent Developments
6.11 CAVAC
6.11.1 CAVAC Corporation Information
6.11.2 CAVAC Overview
6.11.3 CAVAC Avian Influenza Vaccines Sales and Revenue in United States Market (2016-2021)
6.11.4 CAVAC Avian Influenza Vaccines Product Description
6.11.5 CAVAC Recent Developments
6.12 Ringpu Biology
6.12.1 Ringpu Biology Corporation Information
6.12.2 Ringpu Biology Overview
6.12.3 Ringpu Biology Avian Influenza Vaccines Sales and Revenue in United States Market (2016-2021)
6.12.4 Ringpu Biology Avian Influenza Vaccines Product Description
6.12.5 Ringpu Biology Recent Developments
6.13 Vaksindo
6.13.1 Vaksindo Corporation Information
6.13.2 Vaksindo Overview
6.13.3 Vaksindo Avian Influenza Vaccines Sales and Revenue in United States Market (2016-2021)
6.13.4 Vaksindo Avian Influenza Vaccines Product Description
6.13.5 Vaksindo Recent Developments
6.14 ChengDu Tecbond
6.14.1 ChengDu Tecbond Corporation Information
6.14.2 ChengDu Tecbond Overview
6.14.3 ChengDu Tecbond Avian Influenza Vaccines Sales and Revenue in United States Market (2016-2021)
6.14.4 ChengDu Tecbond Avian Influenza Vaccines Product Description
6.14.5 ChengDu Tecbond Recent Developments
6.15 Sindh Poultry Vaccine Centre
6.15.1 Sindh Poultry Vaccine Centre Corporation Information
6.15.2 Sindh Poultry Vaccine Centre Overview
6.15.3 Sindh Poultry Vaccine Centre Avian Influenza Vaccines Sales and Revenue in United States Market (2016-2021)
6.15.4 Sindh Poultry Vaccine Centre Avian Influenza Vaccines Product Description
6.15.5 Sindh Poultry Vaccine Centre Recent Developments
6.16 Merck Animal Health
6.16.1 Merck Animal Health Corporation Information
6.16.2 Merck Animal Health Overview
6.16.3 Merck Animal Health Avian Influenza Vaccines Sales and Revenue in United States Market (2016-2021)
6.16.4 Merck Animal Health Avian Influenza Vaccines Product Description
6.16.5 Merck Animal Health Recent Developments
6.17 Medion
6.17.1 Medion Corporation Information
6.17.2 Medion Overview
6.17.3 Medion Avian Influenza Vaccines Sales and Revenue in United States Market (2016-2021)
6.17.4 Medion Avian Influenza Vaccines Product Description
6.17.5 Medion Recent Developments
6.18 Avimex Animal Health
6.18.1 Avimex Animal Health Corporation Information
6.18.2 Avimex Animal Health Overview
6.18.3 Avimex Animal Health Avian Influenza Vaccines Sales and Revenue in United States Market (2016-2021)
6.18.4 Avimex Animal Health Avian Influenza Vaccines Product Description
6.18.5 Avimex Animal Health Recent Developments
6.19 JOVAC
6.19.1 JOVAC Corporation Information
6.19.2 JOVAC Overview
6.19.3 JOVAC Avian Influenza Vaccines Sales and Revenue in United States Market (2016-2021)
6.19.4 JOVAC Avian Influenza Vaccines Product Description
6.19.5 JOVAC Recent Developments
6.20 Bio-Labs
6.20.1 Bio-Labs Corporation Information
6.20.2 Bio-Labs Overview
6.20.3 Bio-Labs Avian Influenza Vaccines Sales and Revenue in United States Market (2016-2021)
6.20.4 Bio-Labs Avian Influenza Vaccines Product Description
6.20.5 Bio-Labs Recent Developments
7 United States Avian Influenza Vaccines Production Capacity, Analysis
7.1 United States Avian Influenza Vaccines Production Capacity, 2016-2027
7.2 Avian Influenza Vaccines Production Capacity of Key Manufacturers in United States Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Avian Influenza Vaccines Supply Chain Analysis
9.1 Avian Influenza Vaccines Industry Value Chain
9.2 Avian Influenza Vaccines Upstream Market
9.3 Avian Influenza Vaccines Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Avian Influenza Vaccines Distributors and Sales Agents in United States Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of Tables
Table 1. Key Players of Avian Influenza Vaccines in United States Market
Table 2. Top Avian Influenza Vaccines Players in United States Market, Ranking by Revenue (2019)
Table 3. United States Avian Influenza Vaccines Revenue by Companies, (US$, Mn), 2016-2021
Table 4. United States Avian Influenza Vaccines Revenue Share by Companies, 2016-2021
Table 5. United States Avian Influenza Vaccines Sales by Companies, (M Doses), 2016-2021
Table 6. United States Avian Influenza Vaccines Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Avian Influenza Vaccines Price (2016-2021) & (USD/K Doses)
Table 8. Manufacturers Avian Influenza Vaccines Product Type
Table 9. List of Tier 1 Avian Influenza Vaccines Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Avian Influenza Vaccines Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of H5+H7 Avian Influenza Vaccines
Table 12. Major Manufacturers of H9 Avian Influenza Vaccines
Table 13. By Type - United States Avian Influenza Vaccines Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - United States Avian Influenza Vaccines Revenue (US$, Mn), 2016-2021
Table 15. By Type - United States Avian Influenza Vaccines Revenue (US$, Mn), 2022-2027
Table 16. By Type - United States Avian Influenza Vaccines Sales (M Doses), 2016-2021
Table 17. By Type - United States Avian Influenza Vaccines Sales (M Doses), 2022-2027
Table 18. By Application - United States Avian Influenza Vaccines Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - United States Avian Influenza Vaccines Revenue (US$, Mn), 2016-2021
Table 20. By Application - United States Avian Influenza Vaccines Revenue (US$, Mn), 2022-2027
Table 21. By Application - United States Avian Influenza Vaccines Sales (M Doses), 2016-2021
Table 22. By Application - United States Avian Influenza Vaccines Sales (M Doses), 2022-2027
Table 23. Merial Corporation Information
Table 24. Merial Description and Major Businesses
Table 25. Merial Avian Influenza Vaccines Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/K Doses) (2016-2021)
Table 26. Merial Avian Influenza Vaccines Product
Table 27. Merial Recent Developments
Table 28. QYH Biotech Corporation Information
Table 29. QYH Biotech Description and Major Businesses
Table 30. QYH Biotech Avian Influenza Vaccines Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/K Doses) (2016-2021)
Table 31. QYH Biotech Avian Influenza Vaccines Product
Table 32. QYH Biotech Recent Developments
Table 33. DHN Corporation Information
Table 34. DHN Description and Major Businesses
Table 35. DHN Avian Influenza Vaccines Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/K Doses) (2016-2021)
Table 36. DHN Avian Influenza Vaccines Product
Table 37. DHN Recent Developments
Table 38. HVRI Corporation Information
Table 39. HVRI Description and Major Businesses
Table 40. HVRI Avian Influenza Vaccines Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/K Doses) (2016-2021)
Table 41. HVRI Avian Influenza Vaccines Product
Table 42. HVRI Recent Developments
Table 43. CEVA Corporation Information
Table 44. CEVA Description and Major Businesses
Table 45. CEVA Avian Influenza Vaccines Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/K Doses) (2016-2021)
Table 46. CEVA Avian Influenza Vaccines Product
Table 47. CEVA Recent Developments
Table 48. Elanco (Lohmann ) Corporation Information
Table 49. Elanco (Lohmann ) Description and Major Businesses
Table 50. Elanco (Lohmann ) Avian Influenza Vaccines Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/K Doses) (2016-2021)
Table 51. Elanco (Lohmann ) Avian Influenza Vaccines Product
Table 52. Elanco (Lohmann ) Recent Developments
Table 53. Yebio Corporation Information
Table 54. Yebio Description and Major Businesses
Table 55. Yebio Avian Influenza Vaccines Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/K Doses) (2016-2021)
Table 56. Yebio Avian Influenza Vaccines Product
Table 57. Yebio Recent Developments
Table 58. Zoetis Corporation Information
Table 59. Zoetis Description and Major Businesses
Table 60. Zoetis Avian Influenza Vaccines Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/K Doses) (2016-2021)
Table 61. Zoetis Avian Influenza Vaccines Product
Table 62. Zoetis Recent Developments
Table 63. FATRO Corporation Information
Table 64. FATRO Description and Major Businesses
Table 65. FATRO Avian Influenza Vaccines Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/K Doses) (2016-2021)
Table 66. FATRO Avian Influenza Vaccines Product
Table 67. FATRO Recent Developments
Table 68. Kyoto Biken Corporation Information
Table 69. Kyoto Biken Description and Major Businesses
Table 70. Kyoto Biken Avian Influenza Vaccines Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/K Doses) (2016-2021)
Table 71. Kyoto Biken Avian Influenza Vaccines Product
Table 72. Kyoto Biken Recent Developments
Table 73. CAVAC Corporation Information
Table 74. CAVAC Description and Major Businesses
Table 75. CAVAC Avian Influenza Vaccines Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/K Doses) (2016-2021)
Table 76. CAVAC Avian Influenza Vaccines Product
Table 77. CAVAC Recent Developments
Table 78. Ringpu Biology Corporation Information
Table 79. Ringpu Biology Description and Major Businesses
Table 80. Ringpu Biology Avian Influenza Vaccines Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/K Doses) (2016-2021)
Table 81. Ringpu Biology Avian Influenza Vaccines Product
Table 82. Ringpu Biology Recent Developments
Table 83. Vaksindo Corporation Information
Table 84. Vaksindo Description and Major Businesses
Table 85. Vaksindo Avian Influenza Vaccines Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/K Doses) (2016-2021)
Table 86. Vaksindo Avian Influenza Vaccines Product
Table 87. Vaksindo Recent Developments
Table 88. ChengDu Tecbond Corporation Information
Table 89. ChengDu Tecbond Description and Major Businesses
Table 90. ChengDu Tecbond Avian Influenza Vaccines Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/K Doses) (2016-2021)
Table 91. ChengDu Tecbond Avian Influenza Vaccines Product
Table 92. ChengDu Tecbond Recent Developments
Table 93. Sindh Poultry Vaccine Centre Corporation Information
Table 94. Sindh Poultry Vaccine Centre Description and Major Businesses
Table 95. Sindh Poultry Vaccine Centre Avian Influenza Vaccines Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/K Doses) (2016-2021)
Table 96. Sindh Poultry Vaccine Centre Avian Influenza Vaccines Product
Table 97. Sindh Poultry Vaccine Centre Recent Developments
Table 98. Merck Animal Health Corporation Information
Table 99. Merck Animal Health Description and Major Businesses
Table 100. Merck Animal Health Avian Influenza Vaccines Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/K Doses) (2016-2021)
Table 101. Merck Animal Health Avian Influenza Vaccines Product
Table 102. Merck Animal Health Recent Developments
Table 103. Medion Corporation Information
Table 104. Medion Description and Major Businesses
Table 105. Medion Avian Influenza Vaccines Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/K Doses) (2016-2021)
Table 106. Medion Avian Influenza Vaccines Product
Table 107. Medion Recent Developments
Table 108. Avimex Animal Health Corporation Information
Table 109. Avimex Animal Health Description and Major Businesses
Table 110. Avimex Animal Health Avian Influenza Vaccines Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/K Doses) (2016-2021)
Table 111. Avimex Animal Health Avian Influenza Vaccines Product
Table 112. Avimex Animal Health Recent Developments
Table 113. JOVAC Corporation Information
Table 114. JOVAC Description and Major Businesses
Table 115. JOVAC Avian Influenza Vaccines Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/K Doses) (2016-2021)
Table 116. JOVAC Avian Influenza Vaccines Product
Table 117. JOVAC Recent Developments
Table 118. Bio-Labs Corporation Information
Table 119. Bio-Labs Description and Major Businesses
Table 120. Bio-Labs Avian Influenza Vaccines Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/K Doses) (2016-2021)
Table 121. Bio-Labs Avian Influenza Vaccines Product
Table 122. Bio-Labs Recent Developments
Table 123. Avian Influenza Vaccines Production Capacity (M Doses) of Key Manufacturers in United States Market, 2019-2021 (M Doses)
Table 124. United States Avian Influenza Vaccines Capacity Market Share of Key Manufacturers, 2019-2021
Table 125. Avian Influenza Vaccines Market Opportunities & Trends in United States Market
Table 126. Avian Influenza Vaccines Market Drivers in United States Market
Table 127. Avian Influenza Vaccines Market Restraints in United States Market
Table 128. Avian Influenza Vaccines Raw Materials
Table 129. Avian Influenza Vaccines Raw Materials Suppliers in United States Market
Table 130. Typical Avian Influenza Vaccines Downstream
Table 131. Avian Influenza Vaccines Downstream Clients in United States Market
Table 132. Avian Influenza Vaccines Distributors and Sales Agents in United States Market
List of Figures
Figure 1. Avian Influenza Vaccines Product Picture
Figure 2. Avian Influenza Vaccines Segment by Type
Figure 3. Avian Influenza Vaccines Segment by Application
Figure 4. United States Avian Influenza Vaccines Market Overview: 2020
Figure 5. United States Avian Influenza Vaccines Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. United States Avian Influenza Vaccines Revenue, 2016-2027 (US$, Mn)
Figure 7. Avian Influenza Vaccines Sales in United States Market: 2016-2027 (M Doses)
Figure 8. The Top 3 and 5 Players Market Share by Avian Influenza Vaccines Revenue in 2020
Figure 9. H5+H7 Avian Influenza Vaccines Product Picture
Figure 10. H9 Avian Influenza Vaccines Product Picture
Figure 11. By Type - United States Avian Influenza Vaccines Sales Market Share, 2016-2027
Figure 12. By Type - United States Avian Influenza Vaccines Revenue Market Share, 2016-2027
Figure 13. By Type - United States Avian Influenza Vaccines Price (USD/K Doses), 2016-2027
Figure 14. Chicken Avian Influenza Vaccines
Figure 15. Duck & Goose Avian Influenza Vaccines
Figure 16. Other
Figure 17. By Application - United States Avian Influenza Vaccines Sales Market Share, 2016-2027
Figure 18. By Application - United States Avian Influenza Vaccines Revenue Market Share, 2016-2027
Figure 19. By Application - United States Avian Influenza Vaccines Price (USD/K Doses), 2016-2027
Figure 20. Merial Avian Influenza Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 21. QYH Biotech Avian Influenza Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. DHN Avian Influenza Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. HVRI Avian Influenza Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. CEVA Avian Influenza Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. Elanco (Lohmann ) Avian Influenza Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. Yebio Avian Influenza Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. Zoetis Avian Influenza Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. FATRO Avian Influenza Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 29. Kyoto Biken Avian Influenza Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 30. CAVAC Avian Influenza Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 31. Ringpu Biology Avian Influenza Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 32. Vaksindo Avian Influenza Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 33. ChengDu Tecbond Avian Influenza Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 34. Sindh Poultry Vaccine Centre Avian Influenza Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 35. Merck Animal Health Avian Influenza Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 36. Medion Avian Influenza Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 37. Avimex Animal Health Avian Influenza Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. JOVAC Avian Influenza Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Bio-Labs Avian Influenza Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. United States Avian Influenza Vaccines Production Capacity (M Doses), 2016-2027
Figure 41. Avian Influenza Vaccines Industry Value Chain
Figure 42. Marketing Channels
  • Global Avian Influenza Vaccines Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
    Published: 11-Oct-2021        Price: US 3480 Onwards        Pages: 119
    The Avian Influenza Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. According to our lates......
  • Global Encephalitis Vaccination Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
    Published: 07-Oct-2021        Price: US 3480 Onwards        Pages: 87
    The Encephalitis Vaccination market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. According to our lates......
  • Global 23-Valent Pneumococcal Polysaccharide Vaccine Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
    Published: 07-Oct-2021        Price: US 3480 Onwards        Pages: 84
    The 23-Valent Pneumococcal Polysaccharide Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. A......
  • Global and United States Meningococcal Conjugate Market Size, Status and Forecast 2021-2027
    Published: 06-Oct-2021        Price: US 3900 Onwards        Pages: 106
    Global Meningococcal Conjugate Scope and Market Size Meningococcal Conjugate market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Meningococcal Conjugate market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027. Segment......
  • Global and China H1N1 Vaccines Market Insights, Forecast to 2027
    Published: 05-Oct-2021        Price: US 3900 Onwards        Pages: 142
    H1N1 Vaccines market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global H1N1 Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For China market, this report focuses on the H1N1 Vaccines market size by ......
  • Global and China Encephalitis Vaccine Market Insights, Forecast to 2027
    Published: 21-Sep-2021        Price: US 3900 Onwards        Pages: 142
    Encephalitis Vaccine market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Encephalitis Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For China market, this report focuses on the Encephalitis Va......
  • Global Influenza Vaccine Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
    Published: 21-Sep-2021        Price: US 3480 Onwards        Pages: 108
    The Influenza Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. According to our latest resea......
  • United States Influenza Vaccine Market Report & Forecast 2021-2027
    Published: 17-Sep-2021        Price: US 3400 Onwards        Pages: 92
    United States Influenza Vaccine Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (M Doses) United States Influenza Vaccine Market Segment Percentages, By Type, 2020 (%) - Trivalent Influenza Vaccine - Quadrivalent Influenza Vaccine United States Influenza Vaccine Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (M Doses) United States Influenza Vaccine Market Segment Percentages, By Application, 2020 (%) - For Children (6 months to......
  • 2021-2027 Global and Regional 23-Valent Pneumococcal Polysaccharide Vaccine Industry Status and Prospects Professional Market Research Report Standard Version
    Published: 13-Sep-2021        Price: US 3500 Onwards        Pages: 140
    The global 23-Valent Pneumococcal Polysaccharide Vaccine market was valued at 1986.07 Million USD in 2020 and will grow with a CAGR of 14.57% from 2020 to 2027, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(N......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs